Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. UK/
    2. Our innovation /
    3. Focus areas /
    4. Immunology

    Immunology

    slide-images/emea_immunology_research.jpg

    Our focus in immunology

    Johnson & Johnson Innovative Medicine (J&J) understands how distressing and debilitating immune-mediated inflammatory diseases can be, which is why we innovate with purpose to lead where medicine is going.

    Our goal is to improve diagnosis, patients’ access to the best possible treatments and continue to provide new and better medicines.

    Our immunology legacy

    Throughout J&J’s 30-year UK legacy in immunology, we have applied our deep disease and patient insights to deliver transformational treatments for patients with immune-mediated diseases.

    We continue to pioneer therapeutic advances and work closely with healthcare practitioners to help shape the management of immunological conditions.

    We have demonstrated our UK commitment to immunology over the past five years through:1
    135
    Medical education meetings
    40
    Grants and donations
    28
    Clinical publications
    885
    Patients enrolled in clinical trials

    Our treatment areas

    We are proud to offer one of the strongest treatment portfolios for some of the most common immune-mediated inflammatory diseases. Our focus areas include:
    jj-bodyillustration-exterior-femalelowerfaceprofile-colorway01.jpg

    Dermatology

    Psoriasis, a chronic disease affecting the skin for which there is no cure. 2
    jj-bodyillustration-exterior-kneepain-colorway02.jpg

    Rheumatology

    Psoriatic arthritis, inflammation affecting the joints, tendons or ligaments, and rheumatoid arthritis.
    jj-bodyillustration-interior-organ-colon-colorway01.jpg

    Gastroenterology

    Inflammatory bowel disease, encompassing Crohn’s disease, a chronic condition affecting any region of the gastrointestinal tract, and ulcerative colitis, chronic inflammation of the large colon. 3
    We recognise the profound impact that immune-mediated diseases can have on people’s lives. That’s why our dedicated team is committed every day to restoring health and hope for those living with these conditions. We strive to redefine the treatment landscape in the UK by delivering transformational and accessible therapies that aim for durable, symptom-free remission.
    Amy Grey
    Business Unit Director, Immunology, PAH, Value Maximisers Portfolio, and Cross-Operating Company Functions, J&J Innovative Medicine UK
    jj-photo-corkfacility-43.jpg

    Pioneering breakthroughs that change lives

    We’ve always been innovative in our science, finding new and effective ways to transform the course of immune-mediated inflammatory diseases. We continue to advance our understanding of the inflammatory process, working on improved therapies where the impact on patients is high and where there remains a need for better treatments.
    jj-photo-lab-tech-inspecting-substance-in-bottle-im-1star.jpg
    How we work

    Partner with us

    We are committed to partnering with those whose innovative thinking will bring new and creative solutions to the field of medicine
    Reach out

    References
    1: Internal reports from 2019 – 2024.
    2: Psoriasis Association. About Psoriasis. Available at https://www.psoriasis-association.org.uk/treatments-for-psoriasis . Last accessed November 2025.
    3: Crohn’s & Colitis UK. All about Crohn’s and Colitis, Available at https://crohnsandcolitis.org.uk/info-support/information-about-crohns-and-colitis/all-information-about-crohns-and-colitis/understanding-crohns-and-colitis/all-about-crohns-and-colitis . Last accessed November 2025.

    CP-548149 | November 2025